Table 1.
Summary of human subjects
Case no. | Pathologic diagnosis | Age, y | Gender | PMI, h |
---|---|---|---|---|
1 | AD | 79 | M | 4 |
2 | AD | 86 | F | 4 |
3 | AD | 89 | F | 4 |
4 | AD | 81 | F | 4 |
5 | AD | 87 | F | 3 |
6 | AD | 87 | F | 3 |
7 | AD | 100 | F | 3 |
8 | AD | 104 | F | 3.5 |
9 | control | 71 | M | 1.5 |
10 | control | 76 | M | 3.2 |
11 | control | 82 | F | 4.5 |
12 | control | 71 | M | 1.5 |
13 | control | 75 | M | 1 |
14 | control | 64 | M | 3 |
15 | control | 62 | M | 9 |
16 | control | 82 | M | 2 |
AD, Alzheimer’s disease; PMI, postmortem interval.